{"entity":{"type":"insider","cik":"0001468308","url":"/insider/0001468308","json_url":"/insider/0001468308.json","name":"Andrade Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2022-12-30","last":"2024-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Andrade Robert","source":"filing","n_filings":6,"first_seen":"2022-12-30","last_seen":"2024-04-03"}],"transactions":[{"id":2805775,"accession":"0001415889-24-010059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010059","line_url":"/filing/0001415889-24-010059#line-1","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":104271.0,"shares_owned_after_display":"104,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2043405,"accession":"0001415889-24-009204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009204","line_url":"/filing/0001415889-24-009204#line-1","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13975.0,"shares_display":"13,975","price_per_share":10.9013,"price_display":"10.90","price_state":"stated","total_value":152345.6675,"total_display":"152,345.67","total_whole":"152,346","shares_owned_after":91771.0,"shares_owned_after_display":"91,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-26","filed_date":"2024-03-27","scope":"insider"},{"id":2529824,"accession":"0001415889-24-009068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009068","line_url":"/filing/0001415889-24-009068#line-1","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13975.0,"shares_display":"13,975","price_per_share":10.9975,"price_display":"11.00","price_state":"stated","total_value":153690.0625,"total_display":"153,690.06","total_whole":"153,690","shares_owned_after":105746.0,"shares_owned_after_display":"105,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-25","scope":"insider"},{"id":3052343,"accession":"0001415889-24-000781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000781","line_url":"/filing/0001415889-24-000781#line-2","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":156150.0,"total_display":"156,150.00","total_whole":"156,150","shares_owned_after":119721.0,"shares_owned_after_display":"119,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-05","scope":"insider"},{"id":3052338,"accession":"0001415889-24-000781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000781","line_url":"/filing/0001415889-24-000781#line-1","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":159600.0,"total_display":"159,600.00","total_whole":"159,600","shares_owned_after":134721.0,"shares_owned_after_display":"134,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":8589650,"accession":"0001415889-23-010459","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-010459","line_url":"/filing/0001415889-23-010459#line-4","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":8.82,"price_display":"8.82","price_state":"stated","total_value":66150.0,"total_display":"66,150.00","total_whole":"66,150","shares_owned_after":124721.0,"shares_owned_after_display":"124,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"},{"id":8589644,"accession":"0001415889-23-010459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-010459","line_url":"/filing/0001415889-23-010459#line-2","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":8.97,"price_display":"8.97","price_state":"stated","total_value":67275.0,"total_display":"67,275.00","total_whole":"67,275","shares_owned_after":132221.0,"shares_owned_after_display":"132,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-06-30","scope":"insider"},{"id":8589642,"accession":"0001415889-23-010459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-010459","line_url":"/filing/0001415889-23-010459#line-1","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.99,"price_display":"8.99","price_state":"stated","total_value":89900.0,"total_display":"89,900.00","total_whole":"89,900","shares_owned_after":139721.0,"shares_owned_after_display":"139,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-30","scope":"insider"},{"id":6426172,"accession":"0001415889-22-013102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-22-013102","line_url":"/filing/0001415889-22-013102#line-3","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":9.6122,"price_display":"9.61","price_state":"stated","total_value":52867.1,"total_display":"52,867.10","total_whole":"52,867","shares_owned_after":149721.0,"shares_owned_after_display":"149,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2022-12-30","scope":"insider"},{"id":6426168,"accession":"0001415889-22-013102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-013102","line_url":"/filing/0001415889-22-013102#line-2","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":9.5748,"price_display":"9.57","price_state":"stated","total_value":52661.4,"total_display":"52,661.40","total_whole":"52,661","shares_owned_after":155221.0,"shares_owned_after_display":"155,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider"},{"id":6426163,"accession":"0001415889-22-013102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-013102","line_url":"/filing/0001415889-22-013102#line-1","is_derivative":false,"issuer_cik":"0001211583","issuer_name":"FENNEC PHARMACEUTICALS INC.","issuer_ticker":"FENC","issuer_name_source":null,"issuer_url":"/issuer/0001211583","owner_cik":"0001468308","owner_name":"Andrade Robert","owner_display_name":"Andrade Robert","owner_url":"/insider/0001468308","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":9.6145,"price_display":"9.61","price_state":"stated","total_value":105759.5,"total_display":"105,759.50","total_whole":"105,760","shares_owned_after":160721.0,"shares_owned_after_display":"160,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001211583","name":"FENNEC PHARMACEUTICALS INC.","url":"/issuer/0001211583","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":6,"first_seen":"2022-12-30","last_seen":"2024-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001468308","retrieved_at":"2026-08-27T13:14:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}